Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Elgamal

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Urology|February 25, 1998
Re: The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general populationA A Elgamal, L Baert
The Urologic Clinics of North America|June 11, 1999
Vaccine therapy for prostate cancerB A Tjoa, A A Elgamal, G P Murphy
The Prostate|November 27, 1998
ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patientsA A Elgamal, M J Troychak, G P Murphy
CA: a Cancer Journal for Clinicians|January 9, 2001
Modern prostate brachytherapyH Ragde, G L Grado, B Nadir, et al.
The Prostate|February 19, 2000
Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapyG P Murphy, A A Elgamal, M J Troychak, et al.
The Prostate|September 9, 1999
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancerD E Drachenberg, A A Elgamal, R Rowbotham, et al.
Cancer|July 18, 2000
Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-upH Ragde, L J Korb, A A Elgamal, et al.
Urology|July 1, 1994
Immunohistochemical localization of prostate-specific markers within the accessory male sex glands of Cowper, Littre, and MorgagniA A Elgamal, W Van de Voorde, H Van Poppel, et al.
Seminars in Surgical Oncology|January 5, 2000
Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reactionS L Su, A L Boynton, E H Holmes, et al.
Cancer|December 5, 1998
Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigenG P Murphy, A A Elgamal, S L Su, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Urology|February 25, 1998
Re: The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general populationA A Elgamal, L Baert
The Urologic Clinics of North America|June 11, 1999
Vaccine therapy for prostate cancerB A Tjoa, A A Elgamal, G P Murphy
The Prostate|November 27, 1998
ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patientsA A Elgamal, M J Troychak, G P Murphy
CA: a Cancer Journal for Clinicians|January 9, 2001
Modern prostate brachytherapyH Ragde, G L Grado, B Nadir, et al.
The Prostate|February 19, 2000
Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapyG P Murphy, A A Elgamal, M J Troychak, et al.
The Prostate|September 9, 1999
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancerD E Drachenberg, A A Elgamal, R Rowbotham, et al.
Cancer|July 18, 2000
Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-upH Ragde, L J Korb, A A Elgamal, et al.
Urology|July 1, 1994
Immunohistochemical localization of prostate-specific markers within the accessory male sex glands of Cowper, Littre, and MorgagniA A Elgamal, W Van de Voorde, H Van Poppel, et al.
Seminars in Surgical Oncology|January 5, 2000
Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reactionS L Su, A L Boynton, E H Holmes, et al.
Cancer|December 5, 1998
Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigenG P Murphy, A A Elgamal, S L Su, et al.
Pageof 3